$87.99
-4.07[-4.42%]
At close: Apr 24
$87.99
0[0.00%]
After Hours: 6:35PM EDT
Biomarin Pharmaceutical
(NASDAQ:BMRN)Overview Rating
Speculative
Biomarin Pharmaceutical Stock (NASDAQ:BMRN), Quotes and News Summary
Biomarin Pharmaceutical Stock (NASDAQ: BMRN) stock price, news, charts, stock research, profile.
| Open | $92.690 |
| Close | $91.200 |
| Volume / Avg. | 1.600M / 1.404M |
| Day Range | 91.005 - 93.015 |
| 52 Wk Range | 76.020 - 99.560 |
| Market Cap | $16.698B |
| P/E Ratio | 105.793 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 47 |
| Short Interest | 1.63% |
| Days to Cover | 2.74 |
Recent News
No news found
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Biomarin Pharmaceutical Inc.
Sector
Health Care
Industry
Biotechnology
BioMarin's focus is on rare-disease therapies. Genzyme (now part of Sanofi) markets Aldurazyme throu...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Biomarin Pharmaceutical (BMRN) stock?
You can purchase shares of Biomarin Pharmaceutical (NASDAQ: BMRN) through any online brokerage.
Who are Biomarin Pharmaceutical's (BMRN) competitors?
Other companies in Biomarin Pharmaceutical’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
What is the target price for Biomarin Pharmaceutical (BMRN) stock?
The latest price target for Biomarin Pharmaceutical (NASDAQ: BMRN) was reported by Canaccord Genuity on Thursday, February 29, 2024. The analyst firm set a price target for 91.00 expecting BMRN to rise to within 12 months (a possible 3.42% upside). 43 analyst firms have reported ratings in the last year.
Current Stock Price for Biomarin Pharmaceutical (BMRN)?
The stock price for Biomarin Pharmaceutical (NASDAQ: BMRN) is $87.99 last updated April 24, 2024 at 6:35 PM EDT.
Does Biomarin Pharmaceutical (BMRN) pay a dividend?
There are no upcoming dividends for Biomarin Pharmaceutical.
When is Biomarin Pharmaceutical (NASDAQ:BMRN) reporting earnings?
Biomarin Pharmaceutical’s Q1 earnings are confirmed for Wednesday, April 24, 2024.
Is Biomarin Pharmaceutical (BMRN) going to split?
There is no upcoming split for Biomarin Pharmaceutical.
What sector and industry does Biomarin Pharmaceutical (BMRN) operate in?
Biomarin Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.